503.8

-0.73%↓

SANES

9.65

-3.33%↓

SAF

314.4

-3.74%↓

BBVA

18.49

-1.86%↓

BNP

86.83

-2.97%↓

503.8

-0.73%↓

SANES

9.65

-3.33%↓

SAF

314.4

-3.74%↓

BBVA

18.49

-1.86%↓

BNP

86.83

-2.97%↓

503.8

-0.73%↓

SANES

9.65

-3.33%↓

SAF

314.4

-3.74%↓

BBVA

18.49

-1.86%↓

BNP

86.83

-2.97%↓

503.8

-0.73%↓

SANES

9.65

-3.33%↓

SAF

314.4

-3.74%↓

BBVA

18.49

-1.86%↓

BNP

86.83

-2.97%↓

503.8

-0.73%↓

SANES

9.65

-3.33%↓

SAF

314.4

-3.74%↓

BBVA

18.49

-1.86%↓

BNP

86.83

-2.97%↓

Home・Akcijų sąrašas・AB Science SA

AB Science SA

Uždarymo kaina

1.268 -1.25

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.26

Max

1.306

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-5.2M
Pardavimai	515K
Pelno marža	-1,005.243
Darbuotojai	36
EBITDA	-2.5M

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-11

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	86M
Ankstesnė atidarymo kaina	2.52
Ankstesnė uždarymo kaina	1.268

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

1.426 / 1.448 Palaikymas ir pasipriešinimas

AB Science SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-05 23:01; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

2026-03-05 21:54; UTC

Uždarbis

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

2026-03-05 21:35; UTC

Pagrindinės rinkos jėgos

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

2026-03-06 00:00; UTC

Svarbiausios naujienos

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

2026-03-05 23:46; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

2026-03-05 23:33; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026-03-05 23:27; UTC

Rinkos pokalbiai

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

2026-03-05 22:54; UTC

Rinkos pokalbiai

Uždarbis

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

2026-03-05 22:50; UTC

Rinkos pokalbiai

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

2026-03-05 22:48; UTC

Uždarbis

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026-03-05 22:46; UTC

Uždarbis

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

2026-03-05 22:44; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2026-03-05 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-05 21:35; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:32; UTC

Uždarbis

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026-03-05 21:26; UTC

Uždarbis

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

2026-03-05 21:24; UTC

Uždarbis

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

2026-03-05 21:23; UTC

Uždarbis

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

2026-03-05 21:22; UTC

Uždarbis

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco February Digitally-Enabled Sales Rose 21.8% >COST

2026-03-05 21:21; UTC

Uždarbis

Costco Total Co Comparable Sales for February Rose 7.9% >COST

2026-03-05 21:20; UTC

Uždarbis

Costco February Net Sales Were $21.69 B >COST

2026-03-05 21:20; UTC

Uždarbis

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026-03-05 21:20; UTC

Uždarbis

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026-03-05 21:19; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

2026-03-05 21:18; UTC

Uždarbis

Costco 2Q Same-Store Sales Up 7.4% >COST

2026-03-05 21:15; UTC

Uždarbis

Costco 2Q EPS $4.58 >COST

Akcijų palyginimas

Kainos pokytis

AB Science SA Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių AB Science SA akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

1.426 / 1.448Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.